Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

Name: Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic solid tumors, treatment-refractory cancers

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 651242
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.